Atovaquone (Mepron®) Combined With Conventional Chemotherapy for de Novo Acute Myeloid Leukemia (AML)

NCT03568994 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

26

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: Atovaquone
DRUG: Cytarabine
DRUG: Daunorubicin
DRUG: Etoposide
DRUG: Gemtuzumab Ozogamicin

Sponsor

Baylor College of Medicine

Collaborators

[object Object]